| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |